S100A8/A9 (Calprotectin) Is Critical for Development of Glomerulonephritis and Promotes Inflammatory Leukocyte–Renal Cell Interactions
Ruth J. Pepper(University College Hospital), Alan D. Salama(The Royal Free Hospital), Thomas Vogl(Goethe University Frankfurt), H. Terence Cook, Charles D. Pusey(Imperial College Healthcare NHS Trust), Hsu-Han Wang(The Royal Free Hospital), Gayathri Rajakaruna(The Royal Free Hospital), Eugenia Papakrivopoulou(The Royal Free Hospital)
Cited by 51
Related Papers
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
|Annals of the Rheumatic Diseases|2013|454
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
|PLoS Biology|2009|358
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2018|244
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
|Journal of Clinical Investigation|2018|230
CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis
|Journal of Clinical Investigation|2000|176